Weight loss interventions for breast cancer survivors: impact of dietary pattern

Henry J Thompson, Scot M Sedlacek, Mary C Playdon, Pamela Wolfe, John N McGinley, Devchand Paul, Susan G Lakoski, Henry J Thompson, Scot M Sedlacek, Mary C Playdon, Pamela Wolfe, John N McGinley, Devchand Paul, Susan G Lakoski

Abstract

Body weight management is not emphasized in clinical practice guidelines for breast cancer survivors, reflecting the lack of evidence that weight loss improves prognosis. Even if this situation changes, the optimal design for weight loss interventions is unclear. We conducted a 6-month non-randomized, controlled weight loss intervention in 249 post-menopausal breast cancer survivors. This paper reports effects on two secondary endpoints, change in body weight and composition. Participants were predominantly non-Hispanic whites (89%) with a mean age of 54.9 ± 9.2 years, a mean BMI of 29.0 ± 2.6 kg/m: (2) and an average of 43 ± 5% body fat. Two dietary interventions, low fat or low carbohydrate, were investigated and consisted of a 42 day cycle of menus and recipes. Weight loss counseling and anthropometric assessment were provided at monthly clinic visits. One hundred ninety-two women completed the trial (77% retention). In comparison to the nonintervention control, both intervention arms achieved significant decreases in body weight (12.5%), body fat (27.5%), waist circumference (9.5%), and hip circumference (7.8%) (all p < 0.001) with minimal effects on lean mass (1.3% decrease). Median time to 5 and 10% weight loss was 2 (95% confidence interval = 1 to 3) and 4 (95% confidence interval = 3 to 5) months, respectively, and 23% of participants experienced ≥ 15% weight loss. Loss of body weight and fat mass was rapid and substantial irrespective of dietary approach when a structured program was provided with monthly anthropometric assessment and weight loss counseling.

Trial registration: ClinicalTrials.gov NCT01315483.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Flow diagram for screening, assignment,…
Fig 1. Flow diagram for screening, assignment, and follow-up of the study participants.
Fig 2. Cumulative Loss of Body Weight,…
Fig 2. Cumulative Loss of Body Weight, Body Fat, and Lean Body Mass According to Study Group.
(A) average cumulative weight loss (kg); (B) average cumulative fat loss (kg); (C) average cumulative loss of lean mass (kg) as a function of time. Values are means ± SEM. LC, low carbohydrate. LF, low fat.
Fig 3. Percent change in Initial Body…
Fig 3. Percent change in Initial Body Weight According to Intervention Arm by Month of Weight Loss.
Detailed information on individual success in each intervention arm, box plots of the percent change from initial weight by intervention arm at each of the 6 times points were constructed in a format into which a symmetrical dot density plot was integrated. The box plots show each participant’s data as well as indicating the 25th, 50th and 75th percentiles for weight change achieved. These plots show the progressive increments in change in body weight over time by intervention arm and permit a comprehensive view of the magnitude of variation in response.
Fig 4. Time-to-Event Analysis for Weight Loss…
Fig 4. Time-to-Event Analysis for Weight Loss Success According to Intervention Arm.
Kaplan-Meier plots were constructed in order to quantify the time frame over which participants in each intervention arm achieved at least a 5%, or 10% reduction in body weight relative to initial body weight. Each plot shows the percent of women in each arm that achieved at least the stated percent weight loss by month. (A) greater than 90% of all women in both intervention arms achieved at least 5% weight loss with a median time to achieving this goal of 2 months (95% CI = 1 to 3 months). Change occurred more rapidly in the low carbohydrate intervention arm but the differences were not statistically significant, tested using a Cox proportional hazard model controlling for BMI, RMR, steps, and elapsed time from end of treatment. (B) median time to loss of ≥ 10% of initial body weight was 4 months (95% CI = 3 to 5 months). LC, low carbohydrate. LF, low fat.

References

    1. Ewertz M, Jensen MB, Gunnarsdottir KA, Hojris I, Jakobsen EH, Nielsen D, et al. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol. 2011;29: 25–31. 10.1200/JCO.2010.29.7614
    1. Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev. 2012;21: 1244–1259. 10.1158/1055-9965.EPI-12-0485
    1. Byers T, Sedjo RL. Does intentional weight loss reduce cancer risk? Diabetes, Obesity and Metabolism. 2011;13: 1063–1072. 10.1111/j.1463-1326.2011.01464.x
    1. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123: 627–635. 10.1007/s10549-010-0990-0
    1. Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, et al. Breast cancer follow-up and management after primary treatment: american society of clinical oncology clinical practice guideline update. J Clin Oncol. 2013;31: 961–965. 10.1200/JCO.2012.45.9859
    1. Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, et al. American society of clinical oncology position statement on obesity and cancer. J Clin Oncol. 2014;32: 3568–3574. 10.1200/JCO.2014.58.4680
    1. Wadden TA, Butryn ML, Wilson C. Lifestyle modification for the management of obesity. Gastroenterology. 2007;132: 2226–2238.
    1. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63: 2985–3023. 10.1016/j.jacc.2013.11.004
    1. Wadden TA, Webb VL, Moran CH, Bailer BA. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation. 2012;125: 1157–1170. 10.1161/CIRCULATIONAHA.111.039453
    1. Fabian CJ, Kimler BF, Donnelly JE, Sullivan DK, Klemp JR, Petroff BK, et al. Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10% weight loss in postmenopausal women. Breast Cancer Res Treat. 2013;142: 119–132. 10.1007/s10549-013-2730-8
    1. Llanos AA, Krok JL, Peng J, Pennell ML, Olivo-Marston S, Vitolins MZ, et al. Favorable effects of low-fat and low-carbohydrate dietary patterns on serum leptin, but not adiponectin, among overweight and obese premenopausal women: a randomized trial. Springerplus. 2014;3: 175 10.1186/2193-1801-3-175
    1. Reeves MM, Terranova CO, Eakin EG, Demark-Wahnefried W. Weight loss intervention trials in women with breast cancer: a systematic review. Obes Rev. 2014;15: 749–768. 10.1111/obr.12190
    1. Playdon M, Thomas G, Sanft T, Harrigan M, Ligibel J, Irwin M. Weight Loss Intervention for Breast Cancer Survivors: A Systematic Review. Curr Breast Cancer Rep. 2013;1–25.
    1. Martinez JA, Navas-Carretero S, Saris WH, Astrup A. Personalized weight loss strategies-the role of macronutrient distribution. Nat Rev Endocrinol. 2014;10: 749–760. 10.1038/nrendo.2014.175
    1. Johnston BC, Kanters S, Bandayrel K, Wu P, Naji F, Siemieniuk RA, et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA. 2014;312: 923–933. 10.1001/jama.2014.10397
    1. Romieu I, Ferrari P, Rinaldi S, Slimani N, Jenab M, Olsen A, et al. Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr. 2012;96: 345–355. 10.3945/ajcn.111.026724
    1. Sieri S, Pala V, Brighenti F, Agnoli C, Grioni S, Berrino F, et al. High glycemic diet and breast cancer occurrence in the Italian EPIC cohort. Nutr Metab Cardiovasc Dis. 2013;23: 628–634. 10.1016/j.numecd.2012.01.001
    1. Shikany JM, Redden DT, Neuhouser ML, Chlebowski RT, Rohan TE, Simon MS, et al. Dietary glycemic load, glycemic index, and carbohydrate and risk of breast cancer in the Women's Health Initiative. Nutr Cancer. 2011;63: 899–907. 10.1080/01635581.2011.587227
    1. Dong JY, Qin LQ. Dietary glycemic index, glycemic load, and risk of breast cancer: meta-analysis of prospective cohort studies. Breast Cancer Res Treat. 2011;126: 287–294. 10.1007/s10549-011-1343-3
    1. Yun SH, Kim K, Nam SJ, Kong G, Kim MK. The association of carbohydrate intake, glycemic load, glycemic index, and selected rice foods with breast cancer risk: a case-control study in South Korea. Asia Pac J Clin Nutr. 2010;19: 383–392.
    1. Larsson SC, Bergkvist L, Wolk A. Glycemic load, glycemic index and breast cancer risk in a prospective cohort of Swedish women. Int J Cancer. 2009;125: 153–157. 10.1002/ijc.24310
    1. Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, et al. Glycemic index, glycemic load, and chronic disease risk—a meta-analysis of observational studies. Am J Clin Nutr. 2008;87: 627–637.
    1. Sedlacek SM, Playdon MC, Wolfe P, McGinley JN, Wisthoff MR, Daeninck EA, et al. Effect of a Low Fat versus a Low Carbohydrate Weight Loss Dietary Intervention on Biomarkers of Long Term Survival in Breast Cancer Patients ('CHOICE'): Study Protocol. BMC Cancer. 2011;11: 287 10.1186/1471-2407-11-287
    1. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet. 2005;365: 82–93.
    1. Yancy WS Jr., Coffman CJ, Geiselman PJ, Kolotkin RL, Almirall D, Oddone EZ, et al. Considering patient diet preference to optimize weight loss: design considerations of a randomized trial investigating the impact of choice. Contemp Clin Trials. 2013;35: 106–116. 10.1016/j.cct.2013.03.002
    1. Thompson HJ, Sedlacek SM, Paul D, Wolfe P, McGinley JN, Playdon MC, et al. Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors. Breast Cancer Res. 2012;14: R1
    1. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol. 2009;27: 3437–3444. 10.1200/JCO.2008.18.9068
    1. American Cancer Society. Cancer Facts and Figures. Available: . Accessed 11 May 2013.
    1. Foster-Schubert KE, Alfano CM, Duggan CR, Xiao L, Campbell KL, Kong A, et al. Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women. Obesity (Silver Spring). 2012;20: 1628–1638. 10.1038/oby.2011.76
    1. National Institutes of Health. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. Available: . Accessed 11 July 2012.
    1. Patlak M, Nass SJ. The Role of Obesity in Cancer Survival and Recurrence: Workshop Summary. Available: . Accessed 1 August 2012.
    1. IARC Weight Control and Physical Activity In: IARC Handbook of Cancer Prevention. Lyon: IARC Press; 2002. pp. 1–355.
    1. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW. Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults. N Engl J Med. 1999;341: 1097–1105.
    1. Robertson HT, de los CG, Allison DB. Turning the analysis of obesity-mortality associations upside down: modeling years of life lost through conditional distributions. Obesity (Silver Spring). 2013;21: 398–404. 10.1002/oby.20019
    1. Harvie M, Wright C, Pegington M, McMullan D, Mitchell E, Martin B, et al. The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr. 2013;1–14.
    1. Borradaile KE, Halpern SD, Wyatt HR, Klein S, Hill JO, Bailer B, et al. Relationship between treatment preference and weight loss in the context of a randomized controlled trial. Obesity (Silver Spring). 2012;20: 1218–1222. 10.1038/oby.2011.216

Source: PubMed

3
구독하다